Register

Support: 888-992-3836|NewsWire|Home|Login / Register

Home > Boards > US Listed > Biotechs > Autolus Therapeutics plc (AUTL)

AACR II: AUTO6NG https://www.abstractsonline.com/pp8/#!/9045/presentation/7894

Public Reply | Private Reply | Keep | Last Read

Next 10 | Previous | Next

jondoeuk

Followed By	17
Posts	1,258
Boards Moderated	1
Alias Born	10/24/15

160x600 placeholder

Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 1/8/2021 4:16:40 PM

Autolus Therapeutics provides business outlook for 2021 & 2022 GlobeNewswire Inc. - 1/6/2021 4:07:15 AM

Autolus Therapeutics to participate in Investor Conferences through January GlobeNewswire Inc. - 1/4/2021 7:00:00 AM

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 12/7/2020 4:02:13 PM

Autolus Therapeutics presents additional data on AUTO3 in DLBCL during the 62nd ASH Annual Meeting GlobeNewswire Inc. - 12/7/2020 12:01:00 PM

Autolus Therapeutics presents compelling AUTO1 data from ALLCAR Phase 1 study in Adult Acute Lymphoblastic Leukemia (ALL) dur... GlobeNewswire Inc. - 12/5/2020 3:01:00 PM

Autolus Therapeutics announces publication of new AUTO6 Phase 1 data in childhood neuroblastoma in Science Translational Medi... GlobeNewswire Inc. - 11/30/2020 7:00:00 AM

Autolus Therapeutics to host Investor Conference Call to discuss AUTO1 and AUTO3 data presented at ASH and to participate in ... GlobeNewswire Inc. - 11/17/2020 7:00:00 AM

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 11/5/2020 4:04:54 PM

Autolus Therapeutics Reports Third Quarter 2020 Financial Results and Operational Progress GlobeNewswire Inc. - 11/5/2020 7:00:00 AM

Autolus Therapeutics to Report Third Quarter 2020 Financial Results and Host Conference Call on November 5 GlobeNewswire Inc. - 10/30/2020 7:00:10 AM

Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 9/18/2020 8:01:56 AM

Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/18/2020 7:12:50 AM

Autolus Therapeutics presents additional data on AUTO3 in DLBCL during the ESMO Virtual Congress 2020 GlobeNewswire Inc. - 9/18/2020 3:05:10 AM

Autolus Therapeutics to host Investor Conference Call to discuss AUTO3 data presented at ESMO and to participate in Banking c... GlobeNewswire Inc. - 9/8/2020 7:00:10 AM

Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/27/2020 6:04:02 AM

Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 8/13/2020 4:10:04 PM

Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/6/2020 4:07:57 PM

Autolus Therapeutics Reports Second Quarter 2020 Financial Results and Operational Progress GlobeNewswire Inc. - 8/6/2020 7:00:10 AM

Autolus announces changes to its Board and Management Team GlobeNewswire Inc. - 8/4/2020 7:00:10 AM

Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 8/3/2020 4:13:33 PM

Autolus Therapeutics to Report Second Quarter 2020 Financial Results and Host Conference Call on August 6 GlobeNewswire Inc. - 7/30/2020 7:00:10 AM

Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 7/20/2020 4:10:57 PM

Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 7/6/2020 4:16:26 PM

Amended Annual and Transition Report (foreign Private Issuer) (20-f/a) Edgar (US Regulatory) - 6/30/2020 4:14:54 PM

jondoeuk	Friday, 05/15/20 09:18:03 PM
Re: None
Post # of 17

AACR II: AUTO6NG https://www.abstractsonline.com/pp8/#!/9045/presentation/7894

AUTO7 https://www.abstractsonline.com/pp8/#!/9045/presentation/6902

AUTO4/5 https://www.abstractsonline.com/pp8/#!/9045/presentation/7081

Public Reply | Private Reply | Keep | Last Read

Next 10 | Previous | Next

Follow Board

Keyboard Shortcuts

Report TOS Violation

X


Current Price
Change
Volume
Detailed Quote - Discussion Board

+/- to Watchlist

Consent Preferences